Receptor-mediated tumor targeting based on peptide hormones

Expert Opinion on Drug Delivery
Gábor Mezo, Marilena Manea

Abstract

Tumor targeting with peptides is based on the discovery that receptors for many regulatory peptides are overexpressed in tumor cells, compared with their expression in normal tissues. Consequently, these peptides and their analogues can be used as carriers/targeting moieties for the preparation of diagnostic and therapeutic agents that have increased selectivity and decreased peripheral toxicity. Here an overview is given of the most relevant gonadotropin-releasing hormone (GnRH) and somatostatin derivatives, as well as of their applications in cancer diagnosis and therapy. For this purpose, recently published data in these areas (mostly articles published from 2000 to 2009) were reviewed. In contrast to other regulatory peptides that stimulate the tumor growth, GnRH and somatostatin derivatives have inhibitory effect; therefore, they were used primarily for the preparation of various conjugates to be used in targeted chemotherapy, targeted radiotherapy, photodynamic therapy, boron neutron capture therapy and cancer diagnosis. Some of these conjugates have already found clinical applications, whereas others are now in preclinical and clinical trials. Tumor targeting with hormone peptides provides a basis for the development of ...Continue Reading

References

Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R Z CaiA V Schally
Jan 15, 1994·International Journal of Cancer. Journal International Du Cancer·I T Magrath
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·A NagyJ Horvath
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·M KovacsK Groot
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·A NagyZ Kahán
Jan 23, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·S LovasR F Murphy
Jul 17, 1999·European Journal of Endocrinology·A V Schally, A Nagy
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M RadererI Virgolini
Mar 29, 2001·Chemotherapy·K J O'ByrneW P Steward
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H KiarisG Halmos
May 12, 2001·Pathology Oncology Research : POR·A John, G Tuszynski
May 16, 2001·Biochemical and Biophysical Research Communications·J D NeillL C Musgrove
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·R MillarA Katz
Oct 6, 2001·Frontiers in Neuroendocrinology·A V SchallyG Halmos
Mar 21, 2002·Journal of Neuroendocrinology·John A Russell
Apr 20, 2002·Seminars in Nuclear Medicine·Yusuf Menda, Daniel Kahn
Apr 20, 2002·Seminars in Nuclear Medicine·Marion De JongEric P Krenning
Jan 29, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Lisa BodeiGiovanni Paganelli
Mar 6, 2003·Bioorganic & Medicinal Chemistry Letters·Joseph A FuselierDavid H Coy
Mar 6, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·K UlbrichB Ríhová
Jun 24, 2003·Pharmaceutical Research·Sonia S Dharap, Tamara Minko
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·S S DharapT Minko
Sep 8, 2004·Trends in Endocrinology and Metabolism : TEM·Andrew V Schally, Attila Nagy
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gunhild KellerJörg B Engel
Aug 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·S S DharapT Minko
Sep 27, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gunhild KellerJörg B Engel
Jan 27, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Sophia KoukourakiAntonia Dimitrakopoulou-Strauss
Feb 14, 2006·The Journal of Pharmacology and Experimental Therapeutics·Jayant J KhandareTamara Minko

❮ Previous
Next ❯

Citations

Mar 12, 2013·International Journal of Peptides·Federica BarbieriTullio Florio
Nov 30, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Pablo Martín-GagoAntoni Riera
Aug 13, 2011·Journal of Drug Targeting·Lichun SunDavid H Coy
Sep 29, 2011·Journal of Drug Targeting·Giuseppe TrapaniValentino Laquintana
Jun 12, 2010·Expert Opinion on Drug Metabolism & Toxicology·Junya Nagai, Mikihisa Takano
Nov 22, 2012·Journal of Pharmaceutical Sciences·Wei-Liang YeSi-Yuan Zhou
Apr 7, 2012·European Journal of Medicinal Chemistry·Ulrike LeursMarilena Manea
Aug 26, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pascal SchlageMarilena Manea
Sep 3, 2010·Journal of Peptide Science : an Official Publication of the European Peptide Society·Gábor MezöMarilena Manea
Apr 21, 2016·Dalton Transactions : an International Journal of Inorganic Chemistry·Marta SolerMiquel Costas
Feb 26, 2013·Bioorganic & Medicinal Chemistry Letters·Verena Natalie SchreierMarilena Manea
Dec 17, 2014·Organic & Biomolecular Chemistry·N G R Dayan ElshanEugene A Mash
Aug 9, 2012·Bioconjugate Chemistry·Flavia BarragánVicente Marchán
Jan 19, 2017·Molecular Pharmaceutics·Theodoros KarampelasConstantin Tamvakopoulos
May 4, 2017·Chemical Communications : Chem Comm·Vojtech NovohradskyVicente Marchán
Nov 26, 2010·The Journal of Pharmacology and Experimental Therapeutics·Theodora KatsilaConstantin Tamvakopoulos
Nov 14, 2019·International Journal of Molecular Sciences·József MurányiIstván Vályi-Nagy
Sep 11, 2019·International Journal of Molecular Sciences·Eszter LajkóLászló Kőhidai
Jul 11, 2012·Endocrine Reviews·Patrizia LimontaRoberta M Moretti
Aug 21, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lilla PethőGitta Schlosser
Sep 29, 2019·International Journal of Molecular Sciences·Ivan RanđelovićJózsef Tóvári
May 26, 2017·Journal of Labelled Compounds & Radiopharmaceuticals·Kusum VatsAshutosh Dash

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.